Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Non-Small Cell Lung Cancer × Bortezomib × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 9 Solid Tumors 2 Mesothelioma, Malignant 2 Advanced Solid Tumors 2 Unspecified Childhood Solid Tumor, Protocol Specific 1 Advanced or Metastatic Solid Tumors 1 Advanced Non-Small Cell Lung Cancer 1

Interventions

WW Domain-Containing Oxidoreductase 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00064636 2005-06-24

Phase I Dose Escalation Study of VELCADE Plus Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors

Millennium Pharmaceuticals, Inc.

Phase 1 Terminated

Other solid neoplasmThoracic

Advanced Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡